Cargando…
国产达沙替尼治疗慢性髓性白血病慢性期患者的药代动力学研究
OBJECTIVE: To evaluate the pharmacokinetics and bioequivalence of generic dasatinib in patients with chronic myeloid leukemia in the choronie phase (CML-CP). METHODS: Using randomized, parallel, overlapping, self-control designed study, a 100 mg dose of the reference or test tablet was given to 12 C...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348510/ https://www.ncbi.nlm.nih.gov/pubmed/27995880 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.11.006 |
Ejemplares similares
-
国产达沙替尼二线治疗慢性髓性白血病慢性期患者的疗效和安全性分析
Publicado: (2019) -
国产达沙替尼治疗新诊断的慢性髓性白血病慢性期患者疗效及安全性分析
Publicado: (2020) -
国产达沙替尼二线治疗慢性髓性白血病早期分子学反应的预后意义
Publicado: (2019) -
尼洛替尼和达沙替尼作为二三线药物治疗慢性髓性白血病慢性期和加速期患者的疗效及影响因素分析
Publicado: (2020) -
慢性髓性白血病患者达沙替尼相关的肺部不良反应分析
Publicado: (2020)